Cargando…

Amantadine Inhibits SARS-CoV-2 In Vitro

Since the SARS-CoV-2 pandemic started in late 2019, the search for protective vaccines and for drug treatments has become mandatory to fight the global health emergency. Travel restrictions, social distancing, and face masks are suitable counter measures, but may not bring the pandemic under control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fink, Klaus, Nitsche, Andreas, Neumann, Markus, Grossegesse, Marica, Eisele, Karl-Heinz, Danysz, Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063946/ https://www.ncbi.nlm.nih.gov/pubmed/33804989 http://dx.doi.org/10.3390/v13040539

Ejemplares similares

Evaluation of a commercial ELISA as alternative to plaque reduction neutralization test to detect neutralizing antibodies against SARS-CoV-2
por: Hofmann, Natalie, et al.
Publicado: (2022)

Application of spectral library prediction for parallel reaction monitoring of viral peptides
por: Grossegesse, Marica, et al.
Publicado: (2021)

Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro
por: Zhou, Yuyong, et al.
Publicado: (2021)

Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials
por: Danysz, Wojciech, et al.
Publicado: (2021)

Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro
por: Toft-Bertelsen, Trine Lisberg, et al.
Publicado: (2021)

Longitudinal SARS-CoV-2 seroepidemiological investigation among healthcare workers at a tertiary care hospital in Germany
por: Tomczyk, Sara, et al.
Publicado: (2022)

Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro
por: Toft-Bertelsen, Trine Lisberg, et al.
Publicado: (2021)

Resource-efficient internally controlled in-house real-time PCR detection of SARS-CoV-2
por: Michel, Janine, et al.
Publicado: (2021)

Prominent Efficacy of Amantadine against Human Borna Disease Virus Infection In Vitro and In Vivo. Comment on Fink et al. Amantadine Inhibits SARS-CoV-2 In Vitro. Viruses 2021, 13, 539
por: Bode, Liv, et al.
Publicado: (2022)

Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2
por: Cortés-Borra, Albert, et al.
Publicado: (2021)

Combined Proteomics/Genomics Approach Reveals Proteomic Changes of Mature Virions as a Novel Poxvirus Adaptation Mechanism
por: Grossegesse, Marica, et al.
Publicado: (2017)

A Next-Generation Sequencing Approach Uncovers Viral Transcripts Incorporated in Poxvirus Virions
por: Grossegesse, Marica, et al.
Publicado: (2017)

Risk estimation of SARS-CoV-2 transmission from bluetooth low energy measurements
por: Sattler, Felix, et al.
Publicado: (2020)

Observational study of people infected with SARS-Cov-2, treated with amantadine
por: Aranda-Abreu, Gonzalo Emiliano, et al.
Publicado: (2020)

Visualization of SARS-CoV-2 particles in naso/oropharyngeal swabs by thin section electron microscopy
por: Laue, Michael, et al.
Publicado: (2023)

Analysis of two choir outbreaks acting in concert to characterize long- range transmission risks through SARS-CoV-2, Berlin, Germany, 2020
por: Reichert, Felix, et al.
Publicado: (2022)

Global ubiquitination analysis reveals extensive modification and proteasomal degradation of cowpox virus proteins, but preservation of viral cores
por: Grossegesse, Marica, et al.
Publicado: (2018)

THE EFFECT OF N-ACETYL-D-GALACTOSAMINE AND AMANTADINE HYDROCHLORIDE ON EQUINE LYMPHOCYTES STIMULATED WITH PHYTOHEMAGGLUTININ
por: Pogo, Beatriz G. T.
Publicado: (1969)

Psychotic Disorders in the Course of SARS-CoV-2 Infection or Uncomplicated Amantadine Treatment?—Case Report
por: Tatar, Dominika, et al.
Publicado: (2022)

SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine
por: Marinescu, Ileana, et al.
Publicado: (2020)

Milk Casein Inhibits Effect of Black Tea Galloylated Theaflavins to Inactivate SARS-CoV-2 In Vitro
por: Nakashio, Maiko, et al.
Publicado: (2023)

Purple: A Computational Workflow for Strategic Selection of Peptides for Viral Diagnostics Using MS-Based Targeted Proteomics
por: Lechner, Johanna, et al.
Publicado: (2019)

Amantadine, COVID-19 and Parkinsonism
por: Wiwanitkit, Viroj
Publicado: (2020)

Antiglycoxidative properties of amantadine – a systematic review and comprehensive in vitro study
por: Nesterowicz, Miłosz, et al.
Publicado: (2022)

Amantadine-assembled nanostimulator enhances dimeric RBD antigen-elicited cross-neutralization against SARS-CoV-2 strains
por: Zhang, Ye, et al.
Publicado: (2022)

PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity
por: He, Sijia, et al.
Publicado: (2020)

SARS-CoV-2 on the neural battleground
por: Pavillet, Clara Eléonore, et al.
Publicado: (2020)

SARS-CoV-2 likes it cool
por: Soares-Schanoski, Alessandra
Publicado: (2020)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Histone mimicry by SARS-CoV-2
por: York, Ashley
Publicado: (2022)

SARS-CoV-2 in penile tissue
por: Thomas, Tim
Publicado: (2022)

N‐Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS‐CoV‐2 Main Protease
por: Koudelka, Tomas, et al.
Publicado: (2020)

Detection and Stability of SARS-CoV-2 Fragments in Wastewater: Impact of Storage Temperature
por: Markt, Rudolf, et al.
Publicado: (2021)

Amantadine Effect on Perceptions of Irritability after Traumatic Brain Injury: Results of the Amantadine Irritability Multisite Study
por: Hammond, Flora M., et al.
Publicado: (2015)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021
por: Puyskens, Andreas, et al.
Publicado: (2021)

Immune correlates of SARS-CoV-2 protection
por: Brown, Matthew
Publicado: (2020)

SARS-CoV-2: too infectious to handle?
por: Coveney, Clarissa, et al.
Publicado: (2020)

Getting to the (germinal) centre of SARS-CoV-2
por: Richter, Felix Clemens, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cjph0t6u41jjeg7vnjc2ui73oq